GSE194434
RNAsequencing of DOT1L inhibitor EPZ5676 treated ALDH1+ and ALDH1- cell populations
Global gene expression profiles obtained after treating cells with DOT1L inhibitor, EPZ5676 Overall design: MDA-MB-468 cells were first treated with DOT1L inhibitor, EPZ5676 for 10 days and then FACS isolated into ALDH1+ and ALDH1- cell populations. Global gene expression profiles that change after treatment with DOT1L inhibitor are reported.